Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-14 4:26 pm Purchase | 13G | ANNEXON INC ANNX | Redmile Group LLC | 8,083,776 9.9% | 3,186,201 (+65.06%) | View |
2024-02-14 4:26 pm Purchase | 13G | ATARA BIOTHERAPEUTICS INC ATRA | Redmile Group LLC | 10,301,409 9.9% | 463,916 (+4.72%) | View |
2024-02-14 4:26 pm Sale | 13G | ADVAXIS INC PAR $0.001 ADXS | Redmile Group LLC | 211,014 1.9% | -121,339 (-36.51%) | View |
2024-02-14 4:26 pm Sale | 13G | IMMUNOGEN INC IMGN | Redmile Group LLC | 16,423,922 5.9% | -3,472,531 (-17.45%) | View |
2024-02-14 4:26 pm Sale | 13G | NEUROGENE INC NGNE | Redmile Group LLC | 1,050,304 8.1% | -232,357 (-18.12%) | View |
2024-02-14 4:26 pm Purchase | 13G | NURIX THERAPEUTICS INC NRIX | Redmile Group LLC | 5,021,886 9.9% | 122,114 (+2.49%) | View |
2024-02-14 4:26 pm Purchase | 13G | RAPT THERAPEUTICS INC RAPT | Redmile Group LLC | 3,776,847 9.9% | 97,009 (+2.64%) | View |
2024-02-14 4:26 pm Purchase | 13G | DECIPHERA PHARMACEUTICALS INC DCPH | Redmile Group LLC | 8,359,768 9.9% | 1,251,671 (+17.61%) | View |
2024-02-06 5:15 pm Purchase | 13D | MEDAVAIL HLDGS INC MDVL | Redmile Group LLC | 2,490,137 73% | 2,490,137 (New Position) | View |
2024-01-31 5:15 pm Purchase | 13D | SCIENCE 37 HLDGS INC SNCE | Redmile Group LLC | 994,529 16.5% | 994,529 (New Position) | View |
2023-12-28 4:53 pm Sale | 13D | FATE THERAPEUTICS INC FATE | Redmile Group LLC | 15,049,839 14.9% | -21,257 (-0.14%) | View |
2023-12-26 4:15 pm Purchase | 13D | SHATTUCK LABS INC STTK | Redmile Group LLC | 5,664,892 12% | 44,978 (+0.80%) | View |
2023-12-22 4:15 pm Purchase | 13G | NEUROGENE INC NGNE | Redmile Group LLC | 1,282,661 9.9% | 1,282,661 (New Position) | View |
2023-11-22 4:16 pm Purchase | 13D | AUGMEDIX INC AUGX | Redmile Group LLC | 22,092,211 40.7% | 1,845,891 (+9.12%) | View |
2023-11-17 5:15 pm Purchase | 13G | REGENXBIO INC RGNX | Redmile Group LLC | 4,238,312 9.6% | 2,341,089 (+123.40%) | View |
2023-10-16 5:15 pm Purchase | 13G | ALX ONCOLOGY HLDGS INC ALXO | Redmile Group LLC | 4,991,545 9.6% | 4,991,545 (New Position) | View |
2023-10-12 5:15 pm Purchase | 13G | IMMUNOME INC IMNM | Redmile Group LLC | 3,879,415 9.1% | 3,879,415 (New Position) | View |
2023-07-27 5:15 pm Sale | 13D | NEOLEUKIN THERAPEUTICS INC NLTX | Redmile Group LLC | 2,912,228 6.6% | -118,338 (-3.90%) | View |
2023-06-28 5:15 pm Purchase | 13D | IGM BIOSCIENCES INC IGMS | Redmile Group LLC | 3,291,092 9.9% | 257,595 (+8.49%) | View |
2023-06-21 5:15 pm Purchase | 13D | MEDAVAIL HLDGS INC MDVL | Redmile Group LLC | 124,507,268 73.1% | 65,312,868 (+110.34%) | View |